Clinical trial data show that gastrointestinal adverse effectsincluding nausea, vomiting, diarrhea, and abdominal discomfortoccur in 20-50% of patients initiating GLP-1 therapy, with rates varying by specific agent and dose
Switching between these medications should be done under medical supervision due to potential differences in dosage, side effects, and drug interactions
These pathways regulate blood sugar, appetite, and energy balance
But it doesnt mean you can go crazy eating anything
Participants were fully informed of their rights, including the ability to withdraw from the study at any time, and the confidentiality of their responses was assured
Statements Author contributions ZZ: Conceptualization, Visualization, Writing original draft, Writing review & editing